Doxil®

ALZA Corporation (USA)

Anti-cancer drug for the treatment of refractory ovarian cancer and AIDS-related Kaposi’s sarcoma”
“First marketed product to incorporate STEALTH® technology”
“STEALTH® technology is composed of lipid nanoparticles that incorporate a polyethylene glycol (PEG) coating. This coating helps evade the potential impact of the immune system and enables STEALTH® technology to provide the precise delivery of drugs to disease-specific areas of the body.”
Approved by the FDA in February 2005